{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T08:14:56Z","timestamp":1789546496017,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Medical Directors Association"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.jamda.2011.03.006","type":"journal-article","created":{"date-parts":[[2011,4,22]],"date-time":"2011-04-22T23:33:59Z","timestamp":1303515239000},"page":"565-572","source":"Crossref","is-referenced-by-count":81,"title":["Associations Between the Anticholinergic Risk Scale Score and Physical Function: Potential Implications for Adverse Outcomes in Older Hospitalized Patients"],"prefix":"10.1016","volume":"12","author":[{"given":"Estelle","family":"Lowry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Woodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy L.","family":"Soiza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arduino A.","family":"Mangoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jamda.2011.03.006_bib1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1365-2125.2004.02232.x","article-title":"Drugs with anticholinergic properties and cognitive performance in the elderly: results from the PAQUID Study","volume":"59","author":"Lechevallier-Michel","year":"2005","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jamda.2011.03.006_bib2","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1586\/ecp.10.34","article-title":"Association between prescribing of antimuscarinic drugs and antimuscarinic adverse effects in older people","volume":"3","author":"Bostock","year":"2010","journal-title":"Exp Rev Clin Pharmacol"},{"key":"10.1016\/j.jamda.2011.03.006_bib3","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1177\/0091270006292126","article-title":"The Anticholinergic Drug Scale as a measure of drug-related anticholinergic burden: associations with serum anticholinergic activity","volume":"46","author":"Carnahan","year":"2006","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.jamda.2011.03.006_bib4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.pharmthera.2008.04.006","article-title":"Synthesis, trafficking, and localization of muscarinic acetylcholine receptors","volume":"119","author":"Nathanson","year":"2008","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jamda.2011.03.006_bib5","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/sj.clpt.6100035","article-title":"Anticholinergic drugs and physical function among frail elderly population","volume":"81","author":"Landi","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jamda.2011.03.006_bib6","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1111\/j.1532-5415.2008.02009.x","article-title":"Cumulative anticholinergic exposure is associated with poor memory and executive function in older men","volume":"56","author":"Han","year":"2008","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2011.03.006_bib7","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/ageing\/afh036","article-title":"A\u00a0systematic literature review of factors affecting outcome in older medical patients admitted to hospital","volume":"33","author":"Campbell","year":"2004","journal-title":"Age Ageing"},{"key":"10.1016\/j.jamda.2011.03.006_bib8","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1146\/annurev.pu.13.050192.002315","article-title":"Effects of physical activity on health status in older adults. I: Observational studies","volume":"13","author":"Wagner","year":"1992","journal-title":"Annu Rev Public Health"},{"key":"10.1016\/j.jamda.2011.03.006_bib9","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1001\/jama.1994.03520190064036","article-title":"The relationship of postoperative delirium with psychoactive medications","volume":"272","author":"Marcantonio","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.jamda.2011.03.006_bib10","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1001\/archinte.1995.00430050035004","article-title":"Postoperative delirium. A review of 80 primary data-collection studies","volume":"155","author":"Dyer","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jamda.2011.03.006_bib11","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1001\/archinte.161.8.1099","article-title":"Use of medications with anticholinergic effect predicts clinical severity of delirium symptoms in older medical inpatients","volume":"161","author":"Han","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jamda.2011.03.006_bib12","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1001\/archinternmed.2007.106","article-title":"The anticholinergic risk scale and anticholinergic adverse effects in older persons","volume":"168","author":"Rudolph","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jamda.2011.03.006_bib13","first-page":"61","article-title":"Functional evaluation: the Barthel Index","volume":"14","author":"Mahoney","year":"1965","journal-title":"Md State Med J"},{"key":"10.1016\/j.jamda.2011.03.006_bib14","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0895-4356(02)00585-1","article-title":"How to measure comorbidity. A critical review of available methods","volume":"56","author":"de Groot","year":"2003","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jamda.2011.03.006_bib15","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1471-2407-4-94","article-title":"An electronic application for rapidly calculating Charlson comorbidity score","volume":"4","author":"Hall","year":"2004","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jamda.2011.03.006_bib16","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.archger.2006.11.002","article-title":"Prognostic implications of hyponatremia in elderly hospitalized patients","volume":"45","author":"Chua","year":"2007","journal-title":"Arch Gerontol Geriatr"},{"key":"10.1016\/j.jamda.2011.03.006_bib17","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1001\/archinternmed.2009.513","article-title":"Impact of hospital-associated hyponatremia on selected outcomes","volume":"170","author":"Wald","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jamda.2011.03.006_bib18","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1124\/jpet.109.163188","article-title":"The constitutive activity of the human muscarinic M3 receptor unmasks differences in the pharmacology of anticholinergics","volume":"333","author":"Casarosa","year":"2010","journal-title":"J\u00a0Pharmacol Exp Ther"},{"issue":"Suppl 21","key":"10.1016\/j.jamda.2011.03.006_bib19","first-page":"11","article-title":"Anticholinergic effects of medication in elderly patients","volume":"62","author":"Tune","year":"2001","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.jamda.2011.03.006_bib20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2165\/00002512-199915010-00002","article-title":"Drug-induced cognitive impairment in the elderly","volume":"15","author":"Moore","year":"1999","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jamda.2011.03.006_bib21","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/sj.clpt.6100303","article-title":"Physical and cognitive performance and burden of anticholinergics, sedatives, and ACE inhibitors in older women","volume":"83","author":"Cao","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jamda.2011.03.006_bib22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1365-2125.2009.03411.x","article-title":"Drug Burden Index and physical function in older Australian men","volume":"68","author":"Gnjidic","year":"2009","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jamda.2011.03.006_bib23","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1023\/A:1016705615207","article-title":"Functional status, health problems, age and comorbidity in primary care patients","volume":"10","author":"Wensing","year":"2001","journal-title":"Qual Life Res"},{"key":"10.1016\/j.jamda.2011.03.006_bib24","doi-asserted-by":"crossref","first-page":"M102","DOI":"10.1093\/gerona\/53A.2.M102","article-title":"Impact of chronic diseases on functional limitations in elderly Chinese aged 70 years and over: a cross-sectional and longitudinal survey","volume":"53","author":"Woo","year":"1998","journal-title":"J\u00a0Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.jamda.2011.03.006_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.archger.2010.10.005","article-title":"Physical activity, quality of life and symptoms of depression in community-dwelling and institutionalized older adults","author":"Salguero","year":"2011","journal-title":"Arch Gerontol Geriatr"},{"key":"10.1016\/j.jamda.2011.03.006_bib26","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.amjopharm.2010.06.003","article-title":"A\u00a0pharmacoepidemiologic study of community-dwelling, disabled older women: Factors associated with medication use","volume":"8","author":"Crentsil","year":"2010","journal-title":"Am J Geriatr Pharmacother"},{"key":"10.1016\/j.jamda.2011.03.006_bib27","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/j.1532-5415.2008.01737.x","article-title":"Anticholinergic activity of 107 medications commonly used by older adults","volume":"56","author":"Chew","year":"2008","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2011.03.006_bib28","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1053\/j.ackd.2010.03.008","article-title":"Electrolytes in the aging","volume":"17","author":"Schlanger","year":"2010","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.jamda.2011.03.006_bib29","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1053\/j.ajkd.2008.03.004","article-title":"A\u00a0review of drug-induced hyponatremia","volume":"52","author":"Liamis","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jamda.2011.03.006_bib30","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/archinternmed.2009.229","article-title":"Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study","volume":"169","author":"Carriere","year":"2009","journal-title":"Arch Intern Med"}],"container-title":["Journal of the American Medical Directors Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861011001071?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861011001071?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,7,15]],"date-time":"2018-07-15T07:37:15Z","timestamp":1531640235000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525861011001071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S1525861011001071"],"URL":"https:\/\/doi.org\/10.1016\/j.jamda.2011.03.006","relation":{},"ISSN":["1525-8610"],"issn-type":[{"value":"1525-8610","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}